Skip to main content

Table 4 Differences in HRQOL scores and margins of small effect size by mode of administration

From: Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients

Domain questionnaire and scale

PSAQ-CSAQ mean diff (95% CI)

Margin of small effect size

CSAQ-IVR mean diff (95% CI)

Margin of small effect size

IVR-PSAQ Mean diff (95% CI)

Margin of small effect size

Global/general health

      

PROMIS global mental

− 1.05 (− 2.01, − 0.09)

± 1.67

− 0.77 (− 1.71, 0.17)

± 1.64

1.82 (0.89, 2.75)

± 1.62

PROMIS global physical

− 0.41 (− 1.39, 0.57)

± 1.70

− 0.03 (− 1.00, 0.94)

± 1.69

0.44 (− 0.52, 1.41)

± 1.67

NRS overall QOL

− 1.76 (− 4.10, 0.58)

± 4.09

2.19 (− 0.20, 4.58)

± 4.17

− 0.43 (− 2.85, 1.99)

± 4.22

NRS emotional well-being

− 1.44 (− 3.75, 0.88)

± 4.05

1.82 (− 0.46, 4.10)

± 3.99

− 0.38 (− 2.76, 1.99)

± 4.15

NRS mental well-being

− 0.88 (− 3.06, 1.29)

± 3.80

2.24 (0.06, 4.42)

± 3.81

− 1.36 (− 3.61, 0.89)

± 3.92

Physical function

      

PROMIS physical function

− 0.39 (− 1.35, 0.58)

± 1.68

− 0.05 (− 0.98, 0.88)

± 1.61

0.43 (− 0.48, 1.35)

± 1.60

NRS Physical well-being

− 1.55 (− 3.99, 0.90)

± 4.26

− 0.72 (− 3.15, 1.70)

± 4.18

2.27 (− 0.27, 4.82)

± 4.41

Social function

      

PROMIS social function

− 0.51 (− 1.61, 0.59)

± 1.92

− 0.22 (− 1.28, 0.84)

± 1.84

0.73 (− 0.34, 1.79)

± 1.85

NRS social activity

− 2.43 (− 5.32, 0.46)

± 5.01

− 1.16 (− 3.95, 1.62)

± 4.80

3.59 (0.70, 6.48)

± 4.99

Emotional distress—anxiety

      

PROMIS anxiety

0.77 (− 0.35, 1.88)

± 1.94

0.21 (− 0.88, 1.30)

± 1.89

− 0.98 (− 2.08, 0.12)

± 1.90

NRS anxiety

0.60 (− 2.51, 3.70)

± 5.40

5.01 (2.02, 7.99)

± 5.16

− 5.60 (− 8.54, − 2.66)

± 5.08

PRO-CTCAE anxiety frequency

2.89 (− 0.04, 5.83)

± 5.10

4.36 (1.48, 7.23)

± 4.97

− 7.25 (− 10.2, − 4.33)

± 5.05

PRO-CTCAE anxiety severity

2.66 (− 0.05, 5.37)

± 4.72

3.09 (0.47, 5.72)

± 4.53

− 5.76 (− 8.44, − 3.07)

± 4.64

PRO-CTCAE anxiety interference

1.62 (− 1.03, 4.27)

± 4.62

3.10 (0.62, 5.58)

± 4.28

− 4.72 (− 7.22, − 2.22)

± 4.32

Emotional distress—depression

      

PROMIS depression

0.57 (− 0.47, 1.60)

± 1.80

− 0.56 (− 1.53, 0.41)

± 1.68

− 0.01 (− 0.99, 0.97)

± 1.70

NRS depression

0.75 (− 1.92, 3.42)

± 4.63

3.95 (1.52, 6.39)

± 4.21

− 4.70 (− 7.14, − 2.27)

± 4.21

PRO-CTCAE cheer Frequency

0.62 (− 1.99, 3.23)

± 4.53

3.05 (0.59, 5.51)

± 4.25

− 3.67 (− 6.11, − 1.23)

± 4.22

PRO-CTCAE cheer severity

1.31 (− 1.17, 3.78)

± 4.29

2.66 (0.43, 4.89)

± 3.84

− 3.97 (− 6.27, − 1.66)

± 3.97

PRO-CTCAE cheer interference

1.73 (− 0.64, 4.09)

± 4.11

1.72 (− 0.44, 3.89)

± 3.73

− 3.45 (− 5.67, − 1.23)

± 3.83

PRO-CTCAE sad frequency

1.66 (− 1.10, 4.41)

± 4.78

3.48 (0.88, 6.07)

± 4.47

− 5.13 (− 7.71, − 2.55)

± 4.44

PRO-CTCAE sad severity

0.78 (− 1.75, 3.30)

± 4.38

3.35 (0.91, 5.78)

± 4.20

− 4.12 (− 6.53, − 1.72)

± 4.15

PRO-CTCAE sad interference

1.14 (− 1.36, 3.64)

± 4.34

2.30 (− 0.04, 4.64)

± 4.04

− 3.44 (− 5.79, − 1.09)

± 4.05

Fatigue

      

PROMIS fatigue

0.72 (− 0.34, 1.77)

± 1.84

1.31 (0.25, 2.36)

± 1.82

− 2.02 (− 3.05, − 1.00)

± 1.77

NRS fatigue

1.17 (− 1.89, 4.22)

± 5.32

5.69 (2.68, 8.69)

± 5.19

− 6.85 (− 9.80, − 3.91)

± 5.07

PRO-CTCAE fatigue severity

1.38 (− 1.39, 4.15)

± 4.83

3.34 (0.56, 6.12)

± 4.79

− 4.72 (− 7.46, − 1.98)

± 4.72

PRO-CTCAE fatigue interference

0.47 (− 2.66, 3.60)

± 5.46

4.55 (1.50, 7.60)

± 5.27

− 5.02 (− 8.02, − 2.02)

± 5.17

Sleep

      

PROMIS sleep disturbance

0.90 (− 0.19, 1.98)

± 1.90

− 0.35 (− 1.40, 0.71)

± 1.82

− 0.55 (− 1.62, 0.53)

± 1.86

NRS sleep overall

2.79 (− 0.00, 5.59)

± 4.88

− 0.64 (− 3.36, 2.08)

± 4.69

− 2.15 (− 4.97, 0.67)

± 4.87

PRO-CTCAE sleep severity

3.70 (0.69, 6.72)

± 5.26

2.11 (− 0.88, 5.09)

± 5.16

− 5.81 (− 8.86, − 2.76)

± 5.28

PRO-CTCAE sleep interference

0.39 (− 2.62, 3.39)

± 5.23

4.12 (1.20, 7.04)

± 5.05

− 4.50 (− 7.41, − 1.60)

± 5.02

Pain

      

PROMIS pain intensity

0.16 (− 1.07, 1.40)

± 2.16

1.05 (− 0.20, 2.31)

± 2.18

− 1.22 (− 2.45, 0.02)

± 2.14

PROMIS pain interference

0.56 (− 0.58, 1.70)

± 1.99

0.62 (− 0.51, 1.75)

± 1.95

− 1.18 (− 2.30, − 0.06)

± 1.94

NRS pain frequency

1.53 (− 1.80, 4.85)

± 5.81

1.79 (− 1.53, 5.11)

± 5.74

− 3.32 (− 6.68, 0.04)

± 5.81

NRS pain severity

− 0.02 (− 3.07, 3.03)

± 5.33

2.29 (− 0.76, 5.34)

± 5.26

− 2.27 (− 5.26, 0.72)

± 5.17

PRO-CTCAE pain frequency

− 0.56 (− 4.15, 3.02)

± 6.26

3.60 (− 0.09, 7.29)

± 6.37

− 3.04 (− 6.64, 0.57)

± 6.24

PRO-CTCAE pain severity

− 0.12 (− 3.25, 3.01)

± 5.47

1.96 (− 1.30, 5.22)

± 5.63

− 1.83 (− 5.02, 1.36)

± 5.52

PRO-CTCAE pain interference

− 0.17 (− 3.41, 3.08)

± 5.66

2.68 (− 0.54, 5.89)

± 5.56

− 2.51 (− 5.67, 0.66)

± 5.48

  1. Results in bold text indicate where an upper or lower confidence limit exceeds the margin of small effect size. PSAQ means paper-and-pencil self-administered questionnaire, CSAQ computerized self-administered questionnaire, and IVR questionnaire completed using interactive voice recording. The PROMIS scores were on a T-score metric, whereas NRS and PRO-CTCAE items were transformed to 0–100 scale